Violacein-induced chaperone system collapse underlies multistage antiplasmodial activity
| dc.creator | Tavella, Tatyana Almeida Tavella | |
| dc.creator | Silva, Noeli Soares Melo da | |
| dc.creator | Spillman, Natalie | |
| dc.creator | Andrade, Ana Carolina | |
| dc.creator | Kayano, Vitor | |
| dc.creator | Cassiano, Gustavo Capatti | |
| dc.creator | Vasconcelos, Adrielle Ayumi | |
| dc.creator | Camargo, Antônio Pedro de Castello Branco da Rocha | |
| dc.creator | Silva, Djane Clarys Baia da | |
| dc.creator | Fontinha, Diana | |
| dc.creator | Salazar Alvarez, Luis Carlos | |
| dc.creator | Neves, Bruno Junior | |
| dc.date.accessioned | 2024-09-12T15:12:27Z | |
| dc.date.available | 2024-09-12T15:12:27Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Antimalarial drugs with novel modes of action and wide therapeutic potential are needed to pave the way for malaria eradication. Violacein is a natural compound known for its biological activity against cancer cells and several pathogens, including the malaria parasite, Plasmodium falciparum (Pf). Herein, using chemical genomic profiling (CGP), we found that violacein affects protein homeostasis. Mechanistically, violacein binds Pf chaperones, Pf Hsp90 and Pf Hsp70-1, compromising the latter’s ATPase and chaperone activities. Additionally, violacein-treated parasites exhibited increased protein unfolding and proteasomal degradation. The uncoupling of the parasite stress response reflects the multistage growth inhibitory effect promoted by violacein. Despite evidence of proteotoxic stress, violacein did not inhibit global protein synthesis via UPR activationa process that is highly dependent on chaperones, in agreement with the notion of a violacein-induced proteostasis collapse. Our data highlight the importance of a functioning chaperone−proteasome system for parasite development and differentiation. Thus, a violacein-like small molecule might provide a good scaffold for development of a novel probe for examining the molecular chaperone network and/or antiplasmodial drug design. | |
| dc.identifier.citation | TAVELLA, Tatyana Almeida et al. Violacein-induced chaperone system collapse underlies multistage antiplasmodial activity. ACS Infectious Diseases, Washington, v. 7, n. 4, p. 759-776, 2021. DOI: 10.1021/acsinfecdis.0c00454. Disponível em: https://pubs.acs.org/doi/full/10.1021/acsinfecdis.0c00454. Acesso em: 5 set. 2024. | |
| dc.identifier.doi | 10.1021/acsinfecdis.0c00454 | |
| dc.identifier.issn | e- 2373-8227 | |
| dc.identifier.uri | http://repositorio.bc.ufg.br//handle/ri/25507 | |
| dc.language.iso | eng | |
| dc.publisher.country | Estados unidos | |
| dc.publisher.department | Faculdade de Farmácia - FF (RMG) | |
| dc.rights | Acesso Aberto | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Malaria | |
| dc.subject | Chaperone inhibitor | |
| dc.subject | Chemogenomics | |
| dc.subject | Violacein | |
| dc.subject | Proteostasis | |
| dc.title | Violacein-induced chaperone system collapse underlies multistage antiplasmodial activity | |
| dc.type | Artigo |